Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
Freytag M, Kluth M, Bady E, Hube-Magg C, Makrypidi-Fraune G, Heinzer H, Höflmayer D, Weidemann S, Uhlig R, Huland H, Graefen M, Bernreuther C, Wittmer C, Tsourlakis MC, Minner S, Dum D, Hinsch A, Luebke AM, Simon R, Sauter G, Schlomm T, Möller K.
Freytag M, et al. Among authors: tsourlakis mc.
BMC Cancer. 2020 Dec 18;20(1):1220. doi: 10.1186/s12885-020-07682-8.
BMC Cancer. 2020.
PMID: 33339518
Free PMC article.